Abstract
Abstract Ž . Intraocular coronavirus inoculation results in a biphasic retinal disease in susceptible mice BALBrc characterized by an acute Ž . inflammatory response, followed by retinal degeneration associated with autoimmune reactivity. Resistant mice CD-1 , when similarly Ž . inoculated, only develop the early phase of the disease. Blood-retinal barrier BRB breakdown occurs in the early phase in both strains, coincident with the onset of inflammation. As the inflammation subsides, the extent of retinal vascular leakage is decreased, indicating Ž . that BRB breakdown in experimental coronavirus retinopathy ECOR is primarily due to inflammation rather than to retinal cell Ž . Ž destruction. Vascular endothelial growth factor VEGF is upregulated only in susceptible mice during the secondary retinal . degeneration phase. q 2001 Elsevier Science B.V. All rights reserved. Ž . Vascular endothelial growth factor VEGF is well characterized as an angiogenic agent and a vascular perme-Ž ability factor Senger et al., 1983 Senger et al., , 1986 Roberts and . Palade, 1995; Dvorak et al., 1995; Ozaki et al., 1997 , but recent findings show that it is also involved with the recruitment and activation of inflammatory cells and their Ž adhesion to the vascular endothelium Barleon et al., 1996; . Clauss et al., 1996; Melder et al., 1996; Lu et al., 1999 . A marked upregulation of VEGF occurs in the inner retinas of rats developing experimental autoimmune uveoretinitis Ž . Ž . EAU Luna et al., 1997; Vinores et al., 1998a . In these rats, there is inflammatory cell infiltration and an autoim-Ž . mune reaction with blood-retinal barrier BRB breakdown, but no angiogenesis. Experimental coronavirus Ž . retinopathy ECOR of murine retinas provides a model with inflammatory cell infiltration in the early phase and an autoimmune reaction in the late phase, when BALBrc mice are used. In CD-1 mice, the autoimmune response is 0165-5728r01r$ -see front matter q 2001 Elsevier Science B.V. All rights reserved.
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